Himax Technologies Shares Fall After Q2 Results, Guidance-March 2024-www.financetom.com

Himax Technologies Shares Fall After Q2 Results, Guidance

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Himax Technologies Shares Fall After Q2 Results, Guidance

Aug 8, 2024 8:09 AM

10:50 AM EDT, 08/08/2024 (MT Newswires) -- Himax Technologies ( HIMX ) shares were down over 2% in recent Thursday trading following its quarterly results and Q3 guidance.

The fabless semiconductor manufacturer reported Q2 earnings of $0.169 per diluted ADS, up from $0.005 a year earlier.

Three analysts polled by Capital IQ expected $0.14.

Revenue for the quarter ended June 30 was $239.6 million, up from $235.0 million a year earlier.

Three analysts surveyed by Capital IQ expected $232.8 million.

For Q3, the company said it expects a profit of $0.015 to $0.045 per ADS. Three analysts polled by Capital IQ expect $0.08.

It expects revenue for the quarter to fall 12% to 17% sequentially.

Price: 5.71, Change: -0.16, Percent Change: -2.65

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： CEL-SCI Says Breakthrough Medicine Designation Application Filed in Saudi Arabia for Cancer Immunotherapy

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

CEL-SCI Says Breakthrough Medicine Designation Application Filed in Saudi Arabia for Cancer Immunotherapy

Aug 13, 2025

10:43 AM EDT, 08/13/2025 (MT Newswires) -- CEL-SCI ( CVM ) said Wednesday a breakthrough medicine designation application has been filed for head and neck cancer immunotherapy Multikine by an undisclosed Saudi Arabian pharmaceutical firm with the Saudi Food and Drug Authority. CEL-SCI ( CVM ) signed a memorandum of understanding with the Saudi Arabian firm for the commercialization of...

Oklo Selected For Three Projects Under DOE's Reactor Pilot Program

Aug 13, 2025

Oklo Inc. ( OKLO ) shares are trading higher on Wednesday. The firm and its subsidiary Atomic Alchemy have been chosen for three projects under the U.S. Department of Energy's new Reactor Pilot Program. The advanced nuclear developer secured two project slots, while its isotope production arm claimed one, aiming to fast-track the demonstration of test reactors in the U.S....

Creative Medical Says FDA Grants Fast Track Designation to its Lead Investigational Therapy for Chronic Lower Back Pain

Aug 13, 2025

10:42 AM EDT, 08/13/2025 (MT Newswires) -- Creative Medical Technology ( CELZ ) said Wednesday the US Food and Drug Administration has granted fast track designation to its lead investigational therapy, CELZ-201-DDT, for the treatment of degenerative disc disease, a major cause of chronic lower back pain and disability. The designation enables the company to benefit from quicker FDA interactions,...